Clinical Trials

Showing trials with last updates posted in 2026.

NCT03899155 | RECRUITING | PHASE2
1500 participants

Pan Tumor Rollover Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-29
Start Date:
2019-08-09
Completion:
2029-08-25
Conditions
  • Cancer
Interventions
  • DRUG
No Results Yet
NCT03878459 | ACTIVE_NOT_RECRUITING | PHASE4
120 participants

Dapagliflozin Plus Pioglitazone in T1DM

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-29
Start Date:
2019-08-08
Completion:
2026-03-15
Conditions
  • Type 1 Diabetes Mellitus
Interventions
  • DRUG
No Results Yet
NCT03695250 | TERMINATED | PHASE1/PHASE2
8 participants

BMS-986205 and Nivolumab as First or Second Line Therapy in Treating Patients With Liver Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-29
Start Date:
2018-10-16
Completion:
2020-11-24
Conditions
  • Metastatic Hepatocellular Carcinoma
  • Stage III Hepatocellular Carcinoma AJCC v8
  • Stage IIIA Hepatocellular Carcinoma AJCC v8
  • Stage IIIB Hepatocellular Carcinoma AJCC v8
  • Stage IV Hepatocellular Carcinoma AJCC v8
  • Stage IVA Hepatocellular Carcinoma AJCC v8
  • Stage IVB Hepatocellular Carcinoma AJCC v8
  • Unresectable Hepatocellular Carcinoma
Interventions
  • DRUG
  • BIOLOGICAL
NCT03526835 | RECRUITING | PHASE1/PHASE2
560 participants

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-29
Start Date:
2018-05-02
Completion:
2028-05-31
Conditions
  • Advanced/Metastatic Solid Tumors
  • Colorectal Cancer
  • Gastric Cancer
  • Gastroesophageal-junction Cancer
  • NSCLC
  • HNSCC
  • Head and Neck Squamous Cell Carcinoma
  • Esophageal Cancer
Interventions
  • DRUG
  • COMBINATION_PRODUCT
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page